Cargando…

Cola therapy for oesophageal food bolus impactions a case series

INTRODUCTION: This retrospective case series describes the use of cola to immediately treat complete oesophageal food bolus obstructions in the emergency centre. Short of emergent endoscopy – which is invasive, expensive, not without adverse events, and often unavailable in low-resource settings – n...

Descripción completa

Detalles Bibliográficos
Autores principales: Baerends, Eva P., Boeije, Tom, Van Capelle, Anna, Mullaart-Jansen, Nieke E., Burg, Michael D., Bredenoord, Albert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: African Federation for Emergency Medicine 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399995/
https://www.ncbi.nlm.nih.gov/pubmed/30873351
http://dx.doi.org/10.1016/j.afjem.2018.09.005
_version_ 1783399864923586560
author Baerends, Eva P.
Boeije, Tom
Van Capelle, Anna
Mullaart-Jansen, Nieke E.
Burg, Michael D.
Bredenoord, Albert J.
author_facet Baerends, Eva P.
Boeije, Tom
Van Capelle, Anna
Mullaart-Jansen, Nieke E.
Burg, Michael D.
Bredenoord, Albert J.
author_sort Baerends, Eva P.
collection PubMed
description INTRODUCTION: This retrospective case series describes the use of cola to immediately treat complete oesophageal food bolus obstructions in the emergency centre. Short of emergent endoscopy – which is invasive, expensive, not without adverse events, and often unavailable in low-resource settings – no other proven therapies exist to relieve oesophageal food impactions. METHODS: We performed a chart review of adults with complete oesophageal food bolus obstructions presenting to two Dutch emergency centres. Our primary outcome was cola’s success rate in resolving the obstruction. Our secondary outcome was adverse event occurrence. RESULTS: We identified 22 cola interventions in 19 patients, the majority of whom (77.3%) were male. The median age was 59 years (IQR 29–73). All presentations were due to meat impaction. Endoscopy revealed relevant upper gastrointestinal pathology in 54.5%. When initiated in the emergency centre, cola successfully resolved 59% of complete oesophageal obstructions. No adverse events were reported in patients successfully treated with cola. DISCUSSION: While keenly aware of our retrospective study’s limitations, we found a promising success rate for cola as an acute intervention for oesophageal food bolus impactions. We registered no adverse events attributable to cola. Also, given that cola is cheap, widely available and seemingly safe we believe it can be considered in patients with oesophageal obstructions due to food, either as pre-endoscopy treatment or in case endoscopy is not available at all. We think our findings provide an impetus for prospective research on this intervention.
format Online
Article
Text
id pubmed-6399995
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher African Federation for Emergency Medicine
record_format MEDLINE/PubMed
spelling pubmed-63999952019-03-14 Cola therapy for oesophageal food bolus impactions a case series Baerends, Eva P. Boeije, Tom Van Capelle, Anna Mullaart-Jansen, Nieke E. Burg, Michael D. Bredenoord, Albert J. Afr J Emerg Med Original article INTRODUCTION: This retrospective case series describes the use of cola to immediately treat complete oesophageal food bolus obstructions in the emergency centre. Short of emergent endoscopy – which is invasive, expensive, not without adverse events, and often unavailable in low-resource settings – no other proven therapies exist to relieve oesophageal food impactions. METHODS: We performed a chart review of adults with complete oesophageal food bolus obstructions presenting to two Dutch emergency centres. Our primary outcome was cola’s success rate in resolving the obstruction. Our secondary outcome was adverse event occurrence. RESULTS: We identified 22 cola interventions in 19 patients, the majority of whom (77.3%) were male. The median age was 59 years (IQR 29–73). All presentations were due to meat impaction. Endoscopy revealed relevant upper gastrointestinal pathology in 54.5%. When initiated in the emergency centre, cola successfully resolved 59% of complete oesophageal obstructions. No adverse events were reported in patients successfully treated with cola. DISCUSSION: While keenly aware of our retrospective study’s limitations, we found a promising success rate for cola as an acute intervention for oesophageal food bolus impactions. We registered no adverse events attributable to cola. Also, given that cola is cheap, widely available and seemingly safe we believe it can be considered in patients with oesophageal obstructions due to food, either as pre-endoscopy treatment or in case endoscopy is not available at all. We think our findings provide an impetus for prospective research on this intervention. African Federation for Emergency Medicine 2019-03 2018-10-13 /pmc/articles/PMC6399995/ /pubmed/30873351 http://dx.doi.org/10.1016/j.afjem.2018.09.005 Text en 2019 African Federation for Emergency Medicine. Publishing services provided by Elsevier. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original article
Baerends, Eva P.
Boeije, Tom
Van Capelle, Anna
Mullaart-Jansen, Nieke E.
Burg, Michael D.
Bredenoord, Albert J.
Cola therapy for oesophageal food bolus impactions a case series
title Cola therapy for oesophageal food bolus impactions a case series
title_full Cola therapy for oesophageal food bolus impactions a case series
title_fullStr Cola therapy for oesophageal food bolus impactions a case series
title_full_unstemmed Cola therapy for oesophageal food bolus impactions a case series
title_short Cola therapy for oesophageal food bolus impactions a case series
title_sort cola therapy for oesophageal food bolus impactions a case series
topic Original article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399995/
https://www.ncbi.nlm.nih.gov/pubmed/30873351
http://dx.doi.org/10.1016/j.afjem.2018.09.005
work_keys_str_mv AT baerendsevap colatherapyforoesophagealfoodbolusimpactionsacaseseries
AT boeijetom colatherapyforoesophagealfoodbolusimpactionsacaseseries
AT vancapelleanna colatherapyforoesophagealfoodbolusimpactionsacaseseries
AT mullaartjansenniekee colatherapyforoesophagealfoodbolusimpactionsacaseseries
AT burgmichaeld colatherapyforoesophagealfoodbolusimpactionsacaseseries
AT bredenoordalbertj colatherapyforoesophagealfoodbolusimpactionsacaseseries